A Randomized Single-blind Placebo-controlled Study to Evaluate the Safety and Immunogenicity of Three Candidate HIV-1 Vaccines, pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv, Administered in Combination to Healthy HIV 1 Uninfected Adults

Trial Details:

I Completed
University of Oxford October 01, 2010
MVA.HIVconsv,pSG2.HIVconsv ,ChAdV63.HIVconsv MVA consensus; DNA consensus; ChimpAd63 consensus
ChAdV63.HIVconsv Viral Vector - Adeno
MVA.HIVconsv Viral Vector - Pox
pSG2.HIVconsv DNA
United Kingdom 32